Clinical Trials Medical Discoveries
Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction
From
To
Clinical Trials Medical Discoveries
Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction
Commentary
There was a lot to dissect this week as President Donald Trump once again took aim at federal guidance on childhood vaccines with an executive order. And once again his pitch was unsettling for people who care about public health. Republican Sen. Bill Cassidy of Louisiana, a physician, said: “I’m a doctor. This executive order […]
New Products Services
New AI housekeeping assistant transforms hotel inventory data into instant insights and smarter decision making.
Clinical Trials Medical Discoveries
Findings demonstrate HERV-K is required for senescence-associated inflammation in metabolically challenged cells and is reactivated in plasma of subjects living with obesity
Clinical Trials Medical Discoveries
Presented interim FRONTIER4 data evaluate the long-term safety and efficacy of investigational denecimig across once-weekly, once-every-two-weeks, and once-monthly dosing in hemophilia A participants of all ages and disease severities1,2Denecimig is an investigational subcutaneous FVIIIa-mimetic antibody under review with the US Food and Drug Administration (FDA)1Separate phase 3 explorer10 data observed that concizumab reduced annualized bleeding rate compared to on-demand treatment in children with hemophilia A or B, with inhibitors3
Clinical Trials Medical Discoveries
Presented interim FRONTIER4 data evaluate the long-term safety and efficacy of investigational denecimig across once-weekly, once-every-two-weeks, and once-monthly dosing in hemophilia A participants of all ages and disease severities1,2Denecimig is an investigational subcutaneous FVIIIa-mimetic antibody under review with the US Food and Drug Administration (FDA)1Separate phase 3 explorer10 data observed that concizumab reduced annualized bleeding rate compared to on-demand treatment in children with hemophilia A or B, with inhibitors3
New Products Services
Latest IBM Bob Updates Help Enterprises Deliver Production-Ready Software FastIBM Bob is Built to Optimize the Cost of AI-Driven Development Beyond the ModelIBM Bob Now Offers Pre-Built, Customizable Enterprise Workflows for IBM Z, IBM i, Plus Java Modernization
New Products Services
Latest IBM Bob Updates Help Enterprises Deliver Production-Ready Software FastIBM Bob is Built to Optimize the Cost of AI-Driven Development Beyond the ModelIBM Bob Now Offers Pre-Built, Customizable Enterprise Workflows for IBM Z, IBM i, Plus Java Modernization
New Products Services
Latest IBM Bob Updates Help Enterprises Deliver Production-Ready Software FastIBM Bob is Built to Optimize the Cost of AI-Driven Development Beyond the ModelIBM Bob Now Offers Pre-Built, Customizable Enterprise Workflows for IBM Z, IBM i, Plus Java Modernization
